Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
67.8M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
16.7M
-
Shares change
-
-1.77K
-
Total reported value, excl. options
-
$44M
-
Value change
-
-$6.83K
-
Number of buys
-
8
-
Number of sells
-
-8
-
Price
-
$2.63
Significant Holders of Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) as of Q3 2023
23 filings reported holding CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share as of Q3 2023.
Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.7M shares
of 67.8M outstanding shares and own 24.69% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (13.2M shares), BML Capital Management, LLC (1.94M shares), Driehaus Capital Management LLC (812K shares), VANGUARD GROUP INC (310K shares), SILVERARC CAPITAL MANAGEMENT, LLC (121K shares), Atom Investors LP (78.9K shares), GEODE CAPITAL MANAGEMENT, LLC (66.6K shares), MILLENNIUM MANAGEMENT LLC (58.3K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (55.2K shares), and BlackRock Inc. (31.3K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.